Excess LTCs associated with PUD due to continuing H. pylori infection, US$ |
LTCPUD=(PPUD[w]−PPUD[wo])·CPUD
|
28.09 |
Expected cost per patient with PUD, US$ |
CPUD=Cmed+Chosp
|
249.65 |
Expected cost per patient of PUD-related hospitalization, US$ |
Chosp=PPUD[hosp]·CPUD[hosp]
|
8.90 |
Cost of GI hospitalization event due to PUD, US$ |
CPUD[hosp]
|
8,896.00 |
Probability of GI hospitalization event due to PUD, % |
PPUD[hosp]
|
0.10 |
Expected cost per patient of PUD regardless of hospitalization (managed by medication), US$ |
Cmed=tPUD[med]·CPUD[med]
|
240.75 |
Duration of PUD, years |
tPUD[med]
|
0.50 |
Cost/year of managing PUD with medication, US$ |
CPUD[med]
|
481.50 |
Excess lifetime risk of PUD due to continuing H. pylori infection, % |
PPUD[w]−PPUD[wo]
|
11.25 |
Lifetime risk of developing PUD with continuing H. pylori infection, % |
PPUD[w]
|
15.00 |
Lifetime risk of developing PUD without continuing H. pylori infection, % |
PPUD[wo]
|
3.75 |